CSIMarket Company Name, Ticker, Suppliers, else..


Fresh Tracks Therapeutics Inc   (FRTX)
Other Ticker:  
 

Fresh Tracks Therapeutics Inc

FRTX's Fundamental analysis



Fresh Tracks Therapeutics Inc 's sales fell in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 312

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -3.71 %

Fresh Tracks Therapeutics Inc net loss decreased from $-5 millions, to $-1 millions in IV. Quarter 2023,

• More on FRTX's Growth


Fresh Tracks Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.79 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.49.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.92.


• More on FRTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.85

Fresh Tracks Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 1.79 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.49.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.92.

Fresh Tracks Therapeutics Inc Price to Book Ratio is at 0.39 lower than Industry Avg. of 1052.14. and higher than S&P 500 Avg. of 0

• More on FRTX's Valuation

•  Market Capitalization (Millions $) 4
•  Shares Outstanding (Millions) 5
•  Employees -
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -6
•  Cash Flow (TTM) (Millions $) 2
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 1.85

•  Market Capitalization (Millions $) 4
•  Shares Outstanding (Millions) 5
•  Employees -
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -6
•  Cash Flow (TTM) (Millions $) 2
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 6.98
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.17
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com